Equity Research, Broker Reports, and media content on Hemogenyx Pharmaceuticals

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about Hemogenyx Pharmaceuticals
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on Hemogenyx Pharmaceuticals. We currently have 24 research reports from 3 professional analysts.

Open
1.23p
Range Today
1.11/1.23p
52 Week
1.10/3.40p
Daily Volume
18.9k
# Shares
395.9m
Daily Liquidity
(0.00%)
Pension Liability
£0m
Enterprise Value
£7.60m
Market Cap
£4.87m
Latest PE (hist)
Div Yield
Date Source Announcement
02Apr20 14:05 RNS Second Price Monitoring Extn
02Apr20 14:00 RNS Price Monitoring Extension
28Feb20 18:30 RNS Total Voting Rights
20Feb20 07:00 RNS HEMO-CAR-T cells Effective Against AML in vivo
20Feb20 07:00 RNS HEMO-CAR-T cells Effective Against AML in vivo
11Feb20 07:00 RNS Approval and Issuance of U.S. Hu-PHEC Patent
31Jan20 07:00 RNS Director/PDMR Shareholding
  • Frequency of research reports

     

  • Research reports on

    Hemogenyx Pharmaceuticals

  • Providers covering

    Hemogenyx Pharmaceuticals